📊 Score Breakdown
Offering Ability
90
Cash Runway
65
Float Risk
57
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
43%
🔄 Reverse Split
65%
• 50-day avg $0.43 below $1 exchange minimum
• 12 months cash with weak price
💰 Capital Raise
35%
• Under 12 months cash (12mo)
• Active shelf registration ($100M, 169% of market cap)
💹 Market Data
Market Cap$59.08M
Shares Outstanding57.94M
Float18.40M
Cash$1.76M
Debt$2.72M
Short InterestN/A
🏛 Institutional Holdings
7 institutional holders · 332.4K shares
#1
Morgan Stanley
275.0K shares
#2
Xtx Topco Ltd
54.3K shares
#3
Golden State Wealth Management, Llc
100 shares
+ 4 more holders Sign up free to view →
📉 Short Interest
Short Interest115.4K
Days to Cover1.0
% of Float0.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Sep 30, 2025
424B3
ATM
Apr 30, 2026
EFFECT
EFFECT
Apr 30, 2026
6-K
8K EVENT
Apr 03, 2026
13F-HR
BENEFICIAL OWNERSHIP
Mar 31, 2026
Full SEC filing analysis available with free account →
🔬 More Research for NTCL
📊 NTCL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NTCL Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.